Ubrelvy 50 mg tablet is a prescription medicine containing Ubrogepant for oral use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 20°C and 25°C (68°F and 77°F): excursions permitted between 15°C…
Key facts
- Active ingredient (INN)
- Ubrogepant
- Brand
- Ubrelvy
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 10 packets, 16 packets, 30 packets and 4 more
- Marketing authorisation holder
- Allergan
- Manufacturers
- AllerganSportpharm
- Origin register
- US FDA, United States
- Storage
- Store between 20°C and 25°C (68°F and 77°F): excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 December 2019
- Identifiers
- RxCUI 2268221, 2268227, 2268229 +1DailyMed set ID fd9f9458-fd96-4688-be3f-f77b3d1af6ab, 36106b14-d410-4faf-a361-2871de8198c3NDC 0023-6498, 85766-280Application NDA211765
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 packet in 1 box / 1 tablet in 1 packet | 0023-6498-10 | Allergan | 23 December 2019 |
| 16 packet in 1 box / 1 tablet in 1 packet | 0023-6498-16 | Allergan | 23 December 2019 |
| 30 packet in 1 box / 1 tablet in 1 packet | 0023-6498-30 | Allergan | 23 December 2019 |
| 1 packet in 1 box / 1 tablet in 1 packet | 85766-280-01 | Sportpharm | 29 September 2026 |
| 10 packet in 1 box / 1 tablet in 1 packet | 85766-280-10 | Sportpharm | 29 September 2026 |
| 16 packet in 1 box / 1 tablet in 1 packet | 85766-280-16 | Sportpharm | 29 September 2026 |
| 30 packet in 1 box / 1 tablet in 1 packet | 85766-280-30 | Sportpharm | 29 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 December 2019 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ubrogepant
Clinical summary
Ubrogepant is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Ubrogepant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about UbrogepantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- UBRELVY prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Ubrelvy 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.